New CCOP RFA To Encourage Cancer Control Research; Larger But Fewer Awards Are Likely
In Brief: Lou Carrese, NCI Associate Director, Dies; Myers, Ransahoff Head Two New Organ Systems Group
CTEP’s Clinical Trials Proposals Reshaped By Discussion: BSC Next On Schedule
AIDS Drug Discovery Groups RFA Draws 20 Applications
FCRF Recompetition Intriguing, Involved Various Possibility
Fox Chase Joins Plan For Free Cancer Screening
Nursing Center Moves Onto Campus
Blochs to Sponsor “Fighting Cancer”
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - With five-year cancer survival at an all-time high, does this mean people are living longer?
- Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer
